Free New Tremor Healing with Sound Waves Webinar

Webinar Details

Who Should Attend?
This Tremor Healing with Sound Waves Webinar will teach viewers about this common movement disorder and the treatment options available. At all three webinars, guests will:

  • Understand the various treatment options available for essential tremor.
  • Learn about Neuravive, the procedure that utilizes the new, FDA-approved focused ultrasound technology that treats essential tremor without surgery.
  • Participate in a Q&A session with leading physicians for essential tremor treatments.

Three webinar sessions will be available, all hosted by the Essential Tremor Education Center and featuring different presenters. The three available times are:

  • August 23 – 6 PM EDT (3 PM PDT)
  • August 29 – 6 PM EDT (3 PM PDT)
  • September 13 – 9 PM EDT (6 PM PDT)

Wednesday, August 23, 2017

6:00 – 6:45 PM EDT

Presenter: Michael Kaplitt, MD, PhD
Director of Movement Disorders and Pain
Weill Cornell Brain and Spine Center

Dr. Kaplitt is a board-certified neurosurgeon and is the Director of Movement Disorders and Pain at Weill Cornell Brain and Spine Center. He is consistently named to lists of top physicians in New York, and has received several prestigious awards, including the Young Investigator Award from the American Society for Gene Therapy. He has been featured on the Charlie Rose Show, Good Day New York, Business Insider, and other media for his work in essential tremor and movement disorders. After participating in the focused ultrasound clinical trial, Dr. Kaplitt was the first physician in New York to offer Neuravive after FDA-approval for focused ultrasound was obtained. He currently serves on the editorial board of several prestigious scientific and medical journals, including the Journal of Neurosurgery – widely considered to be the most important in the field.

Tuesday, August 29, 2017

6:00 – 6:45 PM EDT

Presenters: J. Levi Chazen, MD and Diane Huss, PT, DPT, NCS

J. Levi Chazen, MD
Weill Cornell Imaging

Dr. Chazen is a board-certified radiologist specializing in Neuroradiology. He is an Assistant Professor of Radiology at Weill Cornell Medical College and Assistant Attending Radiologist at NewYork-Presbyterian Hospital, Weill Cornell Campus. His clinical expertise in neuroradiology has led to expertise in many minimally invasive procedures, including Neuravive. His research interests involve head and neck imaging and CT-guided minimally invasive procedures, and he is an integral part of the Neuravive delivery team at Weill Cornell Medicine.

Diane Huss, PT, DPT, NCS
Physical Therapist
University of Virginia Medical Center

Dr. Huss is a board-certified neurologic clinical specialist physical therapist. She has extensive experience in the evaluation and treatment of individuals with essential tremor, Parkinson’s disease, and other neurological problems. She is a part of the clinical team at University of Virginia Health System that completed both the first Neuravive treatment and the highest volume of Neuravive treatments for essential tremor in the United States.

Register Today

Check here if text messages containing registration confirmation and access instructions can be sent to this phone number

More Information
If you’d like to find out more information or register over the phone, please call our education team at (844) NO-TREMOR.

Learn About Neuravive Now

Wednesday, September 13, 2017

6:00 – 6:45 PM PDT

Presenter: Ryder Gwinn, MD
Director of Epilepsy Surgery and Functional Neurosurgery
Swedish Neuroscience Institute

Dr. Gwinn is a board-certified neurosurgeon and director of Epilepsy Surgery and Functional Neurosurgery at Swedish Neuroscience Institute. He received his medical degree from University of California, Los Angeles, completed his residency at Georgetown University, and his fellowship at Yale University. His work has led to multiple awards, and he has been named a Regional Top Doctor by Castle Connolly and a Fellow by the American Association of Neurological Surgeons. He believes strongly in finding the least invasive therapy with the highest chance of success for his patients. His research was critical for obtaining FDA-approval for the focused ultrasound technology behind Neuravive.